Chaparral is a desert shrub with a long history of medicinal use, primarily for inflammation, skin conditions, respiratory illness, and joint pain. Native American and Hispanic herbalists in the American Southwest used it for centuries as a tea and topical remedy. Today, interest in chaparral centers on its potent antioxidant compound and early-stage research into antiviral and anticancer properties. However, the herb carries serious liver toxicity risks that limit its practical use.
Traditional Uses of Chaparral
The creosote bush (Larrea tridentata) grows across the deserts of the southwestern United States and northern Mexico. Indigenous peoples brewed the leaves into tea to treat respiratory illness, chickenpox, snakebite, and arthritis pain. Southwestern Native American and Hispanic herbalists also applied it directly to joints affected by rheumatoid arthritis, a practice that continued for generations.
Beyond joint care, chaparral tea was used for cramping pains, allergic problems, and eliminating parasites. Applied externally, it served as a wound-healing poultice meant to reduce inflammation and pain. Modern herbal supplement marketing has expanded these claims to include weight loss, acne, blood cleansing, immune support, and even cancer prevention, though most of these uses lack clinical evidence in humans.
The Antioxidant Behind the Claims
Chaparral’s biological activity comes almost entirely from a single compound called NDGA, a natural polyphenol that makes up 5 to 10% of the leaves’ dry weight and accounts for roughly 80% of all the plant’s phenolic compounds. NDGA is recognized as a powerful antioxidant because of its chemical structure: it contains four hydroxyl groups that can neutralize harmful reactive molecules in the body, including several types of free radicals and oxidative byproducts.
Lab studies show NDGA can neutralize a wide range of damaging molecules, from superoxide and hydrogen peroxide to hydroxyl radicals. It also blocks a specific enzyme involved in producing leukotrienes and prostaglandins, two chemical messengers that drive inflammation. This dual action, both scavenging free radicals and interrupting inflammatory pathways, is what makes chaparral appealing for conditions involving chronic inflammation or oxidative stress.
Anti-Inflammatory and Joint Pain Uses
The traditional use of chaparral for arthritis has some biological backing. Test-tube research confirms that NDGA inhibits key inflammatory processes, which aligns with the long practice of applying chaparral topically to swollen, painful joints. The compound reduces production of inflammatory signaling molecules by blocking the enzyme 5-lipoxygenase, and it also interferes with other immune cell activities like degranulation and phagocytosis.
That said, no clinical trials have tested whether chaparral actually helps people with rheumatoid arthritis or other joint conditions. The evidence remains limited to lab experiments and centuries of traditional use. Topical application to the skin is generally considered lower risk than ingesting the herb, which may explain why herbalists historically favored external use for joint pain.
Antiviral Research
Some of the most promising lab research on chaparral involves its activity against viruses. NDGA derivatives have shown the ability to suppress herpes simplex virus infection in both cell cultures and animal models without signs of toxicity to healthy cells or drug resistance. One derivative was tested against herpes strains that had become resistant to acyclovir (the standard antiviral drug) and successfully inhibited all resistant strains through ten rounds of testing.
Research has also explored activity against human papillomavirus (HPV) and HIV. The antiviral mechanism appears to involve blocking specific gene promoters the viruses need to replicate. These findings are still confined to the laboratory, and no antiviral chaparral product has been approved for clinical use.
Cancer Research in the Lab
NDGA has been tested against a wide array of cancer cell types in laboratory settings, including breast, cervical, pancreatic, prostate, lung, and blood cancers. In breast cancer cells that overexpress a growth receptor called HER2, NDGA triggered cell death and enhanced the effectiveness of the drug trastuzumab, even in cells that had stopped responding to that drug alone. In cervical cancer cells, it slowed growth by activating a protein that acts as a natural brake on cell division.
Animal studies have shown modest results. NDGA delayed tumor growth in mice transplanted with human pancreatic and cervical cancers, and it inhibited lung cancer growth in mice given the compound in their drinking water over four months. In leukemia cells, it induced programmed cell death at very low concentrations. These results are genuinely interesting, but they represent early-stage research. No human cancer trials have validated chaparral as a treatment, and taking chaparral supplements for cancer prevention is not supported by current evidence.
Skin Conditions and Topical Use
Chaparral has been used topically for skin rashes, acne, minor wounds, and general skin irritation. The combination of antioxidant, anti-inflammatory, and antimicrobial properties observed in lab tests provides a reasonable explanation for why it might soothe irritated skin or support wound healing. Traditional preparations involved applying a poultice or wash made from the leaves directly to the affected area. Of all the ways chaparral has been used, topical application is the least controversial from a safety standpoint, since it avoids the liver exposure that makes internal use risky.
Serious Liver Safety Concerns
Chaparral’s most significant drawback is its documented ability to cause liver damage. Reports of hepatotoxicity have been linked to oral doses of the crude herb ranging from 1.5 to 3.5 grams per day. The NIH’s LiverTox database lists chaparral as a known cause of drug-induced liver injury.
Health Canada issued a formal warning telling consumers not to ingest chaparral in any form, whether loose leaves, teas, capsules, or bulk herbal products, because of the risk of liver and kidney problems. The agency issued a customs alert to block importation of chaparral supplements and asked retailers to pull listed products from shelves. No chaparral-containing products are currently approved by Health Canada for any use.
In the United States, chaparral remains legally available as a dietary supplement, but the FDA has also flagged safety concerns. The herb is not regulated as a drug, meaning supplement manufacturers are not required to prove it is safe or effective before selling it.
Forms and Typical Preparations
Chaparral has traditionally been prepared as a tea by steeping one teaspoon of leaves and flowers in a pint of hot water for about 15 minutes. As a tincture, the typical traditional dose was 20 drops up to three times daily. Capsules and tablets containing dried chaparral leaf are also sold commercially.
Given the documented liver toxicity at relatively low doses of the crude herb, these preparations carry real risk when taken internally. If you’re considering chaparral for any reason, the gap between traditional use and proven safety is wide. The antioxidant and anti-inflammatory properties are real at the molecular level, but so is the potential for organ damage when the herb is ingested.